R&D tax credit
This article was originally published in The Gray Sheet
Executive SummarySens. John Danforth (R-Mo.) and Max Baucus (D-Mont.) introduce legislation March 26 that would make permanent the tax credit for research and development, which expired in June 1992. The bill (S 666) would allow companies to update their base period from the current 1984-88 for the purpose of calculating the credit, and to offset a portion of their alternative minimum tax liability with the credit. In addition, the measure would provide a flat-rate credit for certain companies.
You may also be interested in...
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.